glp-1 data RA prescription trends: January 2018 – March 2025 Market Overview: GLP-1 Agonists and
Description
According to the Centers for Disease Control and Prevention (CDC), 9.4% of the population of the United States has Diabetes, including 25.2% of those aged 65 years or older 1
It is reported that ARR1 controls the desensitization of the GLP-1R
The geometry of leptin action in the brain: more complicated than a simple ARC
Because of their reactivity, drug developers must pay special attention to the primary packaging used or risk reformulation and delays in development
With ~$200M invested capital, our new Bridgeton center of excellence for aseptic fill-finish is a fully Annex I compliant injectable contract manufacturing facility
Which GLP-1 RAs are currently available
